ILLUMISONICS INC
  • Home
  • Applications
  • The PARS® Technology
  • Knowledge Base
  • About Us
    • News
    • Our People
    • Partners
    • Careers
  • Contact

​Changing the way 
the world looks at tissue

illumiSonics develops PARS® advanced optical imaging systems 
for a wide range of pre-clinical and clinical applications.

PARS® is a revolutionary microscope for in-situ diagnostics. It is:

  • Non-contact
  • High-resolution
  • Label-free
  • Non-destructive
  • 3D
The PARS®-Technology

PARS® offers ...

  • Imaging at least as good as diagostic-quality H&E histology
  • Images fresh tissues without dyes
  • Images thick tissue samples
  • Contact-free imaging
  • Near real-time feedback (< 5 min)
  • Additional biological information beyond H&E
  • Downstream processing (no staining of samples necessary)
  • AI-supported cloud diagnostics

PARS® Histology will

IMPROVE CANCER
​PATIENT OUTCOMES
PARS® allows diagnostics during surgery, which leads to more precise resections and avoids repeat surgeries.
ENABLE COST SAVINGS
​

PARS® reduces operating room utilization and improves throughput for clinical labs.
ENHANCE THE
DIAGNOSTICS WORKFLOW

PARS® simplifies logistics since diagnostics are done at point-of-care and the tissue container is automatically traced.

The PARS® Shortcut

PARS® delivers gold standard images for histology during surgery. 
Tissue processing is not required.​

Picture
Upper part: tumor board – evaluate histo-pathology results and eventually schedule repeat surgery (15.5%* / 32.5%**) for positive surgical margins

Lower part: evaluate surgical margins intraoperatively and prevent repeat surgeries as left positive margins are identified intraoperatively with gold standard H&E histo-pathology diagnostics

* Adams  BJ, Zoon  CK, Stevenson  C, Chitnavis  P, Wolfe  L, Bear  HD.  
The role of margin status and reexcision in local recurrence following breast conservation surgery.  Ann Surg Oncol. 2013;20(7):2250-2255
** Piper, M.L., Wong, J., Fahrner-Scott, K. et al. 
Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.
​npj Breast Cancer 5, 29 (2019). https://doi.org/10.1038/s41523-019-0125-7
Picture

PARS® Applications under Development

Picture
PARS® MOHS SURGERY SOLUTION
Mohs skin cancer surgery requires multiple steps of tissue removal, each requiring frozen pathology confirmation. The PARS® Mohs system offers images of the same type in less than 5 min. This reduces the treatment time by  approx. 25%.
PARS® IN-SURGERY SOLUTION
Positive surgical margins happen because cancer cells can not always be identified during the operation. PARS® in-surgery system will identify cancer tissue during the surgery. Re-operation becomes unnecessary.
PARS® APPLICATIONS

About illumiSonics

illumiSonics develops, patents and commercializes PARS® advanced optical imaging systems
for a wide range of pre-clinical and clinical applications. Our proprietary PARS®
(​Photon Absorption Remote Sensing- formerly known as Photoacoustic Remote Sensing) technology is a
revolution in optical imaging. We work with market leading partners to develop systems for specific applications. 
About Us

Recent News

Picture
2022 / 11
Dr. Parsin Haji Reza appointed Translational Medical Staff, Wills Eye Hospital  ​
A bylaw approved by the Wills Eye Hospital Staff and the Philadelphia Board of Directors of City Trusts to appoint Dr. Haji Reza as a Translational Medical Staff for 2 years.
Picture
2022 / 03
Researchers' Corner 20/20 Innovation Vision 
Dr. Parsin Haji Reza featured in CIL Researchers' Corner. The feature article focuses on Canada's Recovery - Research is Key: contributions, efforts, achievements, and challenges of our top research performers moving Canada into its recovery stage post pandemic​
read more

Picture
2022 / 03
Top 100 in Physics
Our paper published in Scientific Reports, "Functional and structural ophthalmic imaging using noncontact multimodal photoacoustic remote sensing microscopy and optical coherence tomography," is one of the top 100 most downloaded physics papers that were published in 2021. ​
read more
MORE NEWS

illumiSonics Inc.
22 King Street South, Suite 300
Waterloo, Ontario
N2J 1N8 
​Canada 

PARS® Applications
The PARS® Technology
PARS® Knowledge Base

About Us
Careers

© illumiSonics Inc., 2014-2022 – all rights reserved

  • Home
  • Applications
  • The PARS® Technology
  • Knowledge Base
  • About Us
    • News
    • Our People
    • Partners
    • Careers
  • Contact